Ovarian Cancer Canada is a 3-star charity with an average results reporting grade. Its reserve funds are within Ci’s reasonable range and can cover just under six months of program costs. For every dollar donated to Ovarian Cancer Canada, 58 cents are available to go to the cause, which is outside Ci’s reasonable range.

Ovarian Cancer Canada is the only national charity in Canada dedicated exclusively to overcoming ovarian cancer. Established in 1998, the organization strives for a future where ovarian cancer is preventable and curable. The charity reports that approximately 3,000 Canadians are diagnosed with ovarian cancer each year. To improve outcomes for those affected, it drives vital research, advocates for better screening and treatments, and provides peer-support programs and resources to patients and caregivers nationwide.

The charity operates two main programs: Research and Improve Care. In F2025, Ovarian Cancer Canada spent $4.5m on its programs.

Research was Ovarian Cancer Canada’s largest program in F2025, representing $2.9m, or 67% of its program spending. The charity invested in 17 new research projects in F2025, supporting studies across the different forms of ovarian cancer. These projects focus on advancing prevention, improving early detection, and developing more effective treatments.

Improve Care accounted for $1.4m or 33% of its program spending in F2025. The program focuses on improving access to high-quality ovarian cancer care and prevention. In British Columbia, where only eight gynecologic oncologists previously served a population of 5.5 million, Ovarian Cancer Canada supported advocacy efforts that helped increase the number of specialists to 15. It also expanded access to prevention resources in F2025, providing digital access to 24,775 physicians and 1,739 nurses and nurse practitioners across 11 provinces and territories.

Ovarian Cancer Canada’s audited financial statements follow activity-based costing which is a best practice. This means its expenses are clearly defined between program, administrative, and fundraising categories. The expense breakdown in the F2025 audited financials exceeds reported total expenses by $33k.

Ovarian Cancer Canada had total revenues of $6.8m in F2025. It received $5.0m in donations and special events revenue, equal to 74% of revenue and $1.8m in government funding, amounting to 26% of revenue. The charity also received $2.4m in special events revenue, which is 35% of total revenues.

The charity spent $4.5m on its programs, accounting for 66% of its revenue.

Administrative costs were $804k, representing 12% of revenue (excluding investment income). Ovarian Cancer Canada spent $1.5m on fundraising, equal to 30% of donations. Total overhead spending was 42%. For every dollar donated to Ovarian Cancer Canada, 58 cents are available to go to the cause. This is outside Ci’s reasonable range.

The charity held $2.2m in reserve funds (cash and investments) in F2025. These reserves can cover just under six months of annual program costs. This is within Ci’s reasonable range.

This is a charity update that has been sent to Ovarian Cancer Canada by Neela Jalilian on June 10, 2026.